kisspeptin 112-121

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug Namekisspeptin 112-121
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionKisspeptins receptor agonists
TargetsKisspeptins receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Post-Acute COVID-19 SyndromeIdiopathie hypogonadotropic hypogonadism +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentMassachusetts General Hospital
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Post-Acute COVID-19 SyndromeIdiopathie hypogonadotropic hypogonadism +[11] 
Inactive IndicationsSurgical Wound Infection

Other Information

ATC CodeN/A
Related LinksN/A